Back to News
Market Impact: 0.12
Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform
Source: Business Wire
Company FundamentalsTechnology & InnovationProduct LaunchesPrivate Markets & Venture
Celularity and MuseCell Innovations announced a U.S. manufacturing partnership to produce Dezawa MuseCells at the companies’ Florham Park, NJ facility. The news supports U.S. capacity expansion for the product line, but no financial figures, guidance, or timelines were provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
CELU0.40
More News
- Musk says Terrafab chip factory could outperform rivals despite challenges
- Nvidia GPUs are everywhere. Here are the ways companies are accessing them
- Stocks saw new highs and big declines: How the volatile AI trade moved last week's market
- Will Warner Bros. kill Skydance — or will David Ellison kill Warner Bros?
- The world needs Ukraine’s grain. Its farmers are running out of reasons to plant
- Cerebras Is About as Big as Nvidia's Data Center Business Was Nearly a Decade Ago. The Similarities Mostly End There.